(702) 683-8946

Monday - Friday 9am to 5pm



Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)



CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform




Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business


1351 Result: medical

Bipartisan Budget Agreement: President Biden Hails Historic Achievement for America's Economy and Future

June 02nd, 2023

In a historic moment for the United States, President Joe Biden praised the bipartisan effort displayed by Senators in passing the Bipartisan Budget Agreement. The President emphasized the significance of this achievement, highlighting that it not on. Read more

Chevron, Nevro, America Movil, Hillman Solutions, Grupo Televisa, and ACNB - Assessing Potential Upside and Price Targets

May 31st, 2023

Chevron Corporation (NYSE: CVX), a multinational energy corporation, has been upgraded from Underweight to Neutral by JP Morgan. The price target for $CVX has also been raised from $161 to $170 based on the firm's view.  On Wednesday, $CV. Read more

FDA Conducts Retailer Inspection Blitz, Cracks Down on Illegal Sales of Popular Disposable E-cigarettes

May 31st, 2023

Washington D.C. / CRWE PRESS RELEASE / May 31, 2023 -  Today, the U.S. Food and Drug Administration issued warning letters to 30 retailers, including one distributor, for illegally selling unauthorized tobacco products. The unauth. Read more

Advance Auto Parts Q1 Results Fall Short of Consensus, Lowers Outlook; iRhythm Technologies Reveals FDA Warning Letter

May 31st, 2023

The first quarter of 2023 proved to be challenging for Advance Auto Parts, Inc. (NYSE: AAP), as the company reported diluted earnings per share (EPS) of $0.72, falling short of the consensus estimate of $2.57.  Tom Greco, the president and ch. Read more

NetEase, PagSeguro, Lowe's, Rockwell Medical, Confluent, Salesforce: Analyst Updates and Potential Upside Revealed

May 31st, 2023

NetEase, Inc. (Nasdaq: NTES), a leading Chinese internet technology company providing online gaming, e-commerce, and internet services, had its Buy rating maintained, and the price target was raised from $116 to $127 by BofA Securities. Closing at. Read more

Assessing Upgrades and Initiations: Potential Upside for Boston Beer, Cooper Companies, Constellation Brands, and Equitrans Midstream

May 30th, 2023

Boston Beer Company, Inc. (NYSE: SAM), a leading brewery and beverage company, received an upgrade from ROTH MKM, shifting from Neutral to Buy, along with a raised price target from $274 to $386.  On Tuesday, $SAM closed at $334.93, demonstra. Read more

Acelyrin (SLRN), CRISPR Therapeutics (CRSP), Elevation Oncology (ELEV), STERIS (STE), Teleflex (TFX): Analyst Coverage and Potential Upside Revealed

May 30th, 2023

Acelyrin, Inc. (Nasdaq: SLRN), a pharmaceutical company dedicated to developing innovative therapies, caught the attention of Jefferies, which initiated coverage on the stock with a Buy rating and a price target of $31.  Despite $SLRN closing. Read more

Agreements Boost Aclarion and HeartBeam, Analysts' Eyes on Kenvue

May 30th, 2023

Aclarion, Inc. (Nasdaq: ACON) has entered into a commercial agreement with the prestigious London Clinic, a renowned independent hospital in London's medical district. This collaboration allows Aclarion to leverage the Clinic's advanced facil. Read more

Exploring Analyst Views: Upside Potential for UnitedHealth, Strategic Education, UWM Holdings, CVS Health, Mirion Technologies, Integer

May 28th, 2023

Recent developments in the stock market have brought attention to several companies, with analysts and brokerage firms providing their views on potential price targets. These targets can give investors an idea of the potential upside of a stock based. Read more

Corporate Earnings, Revised Guidance, and Medical Breakthroughs: Insights on Hibbett, Booz Allen Hamilton, and Novo Nordisk

May 26th, 2023

Hibbett, Inc. (Nasdaq: HIBB) released its first-quarter fiscal 2024 earnings per share (EPS) of $2.74, falling short of the consensus estimate of $3.04.  The company revised its full-year fiscal 2024 guidance to reflect a more cautious consum. Read more

Financial Performance and Clinical Updates: 23andMe, RH, and Aravive - Latest Reports and Future Prospects

May 26th, 2023

In the world of financial markets and healthcare, several companies have recently reported their financial performance and provided updates on their ongoing trials and future prospects. Genetic testing company 23andMe Holding Co. (Nasdaq: ME) disc. Read more

FDA Approves First Oral Antiviral for Treatment of COVID-19 in Adults

May 25th, 2023

Silver Spring, MD / CRWE PRESS RELEASE / May 25, 2023  -  Today, the U.S. Food and Drug Administration approved the oral antiviral Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mil. Read more

Statement Regarding the Termination of Boston Scientific Corporation’s Attempted Acquisition of a Majority Stake in M.I. Tech Co., Ltd.

May 24th, 2023

Washington D.C. / CRWE PRESS RELEASE / May 24, 2023 -  In response to the announcement that Boston Scientific Corporation and non-vascular stent manufacturer M.I. Tech Co., Ltd. have terminated their $230 million purchase agreement, Federal. Read more

Market Buzz: Palo Alto Networks, Urban Outfitters, and Inovio See Pre-Market Upswing on Positive Financials and Medical Breakthrough

May 24th, 2023

Palo Alto Networks, Inc. (Nasdaq: PANW) published its financial results for the third quarter of fiscal year 2023, with adjusted earnings per share of $1.10, outperforming the consensus estimate of $0.93. The company also provided forward-looking gui. Read more

Key Partnerships and Promising Initiations: Lifecore Biomedical and Alcon Forge New Agreements, while Avanos, CONMED, and Recursion Pharma Garner Positive Ratings

May 22nd, 2023

Lifecore Biomedical, Inc. (Nasdaq: LFCR) and Alcon Inc. (NYSE: ALC) have entered into a wide-ranging set of agreements, including a new $150 million credit arrangement. This credit facility will enable Lifecore to repay its existing credit agreement . Read more

Load More Content